Contact
Please use this form to send email to PR contact of this press release:
Cristal Therapeutics Starts Clinical Phase I Trial with Nanomedicine CriPec® Docetaxel in Patients with Solid Tumours
TO:
Please use this form to send email to PR contact of this press release:
Cristal Therapeutics Starts Clinical Phase I Trial with Nanomedicine CriPec® Docetaxel in Patients with Solid Tumours
TO: